"We will launch a generic version of the urinary disorder treatment Flomax in March 2010," Ranbaxy Laboratories' Chief Financial Officer, Omesh Sethi, told pharmaquest.biz on the sidelines of a seminar here.

"We would launch another big one in 2014," he said, without naming it.

"We are doing well and expect a good revenue from domestic and global markets in the next financial year," Sethi said.

---

Add this page to your favorite Social Bookmarking websites